Nupo | Klinische onderzoeken

Nupo’s VLCD (Very Low Calorie Diet) producten worden al meer dan 30 jaar gebruikt in Denemarken. Het verhaal van Nupo en onze producten gaat terug tot 1981 en sindsdien hebben we producten ontwikkeld die bijdragen aan effectief en veilig gewichtsverlies. De naam Nupo is een combinatie van de woorden “Nutritional Powder”. Nupo is ontwikkeld in het Hvidovre ziekenhuis in Denemarken door obesitasonderzoeken Dr. Flemming Quaade in samenwerking met het bedrijf Oluf Mørk A/S. Sinds het begin van Nupo zijn alle producten getest en goedgekeurd in meer dan 35 klinische onderzoeken en worden ze continu doorontwikkeld en getest door onderzoeksteam in verschillende ziekenhuizen in Denemarken.

Het onderstaande overzicht bestaat uit klinische onderzoeken vanaf het begin van de oprichting van Nupo tot nu toe. Hierbij wordt er vooral gekeken naar relevante factoren zoals: botmassa, vetvrije massa, vetlichaammassa, cardiovasculaire risicofactoren en het hongergevoel.

KiOnutrime-CsG® - The proven weight management tool

KiOnutrime-CsG® - The proven weight management tool

- by KitoZyme (2015) Introduction KiOnutrime-CsG® is a natural ingredient that is scientifically proven to help people to manage their weight. In...
Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction

Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction

- by V. R. Trivedi et al. (2016) Abstract Chitosan is a dietary fibre which acts by reducing absorption and thus as...
EFSA Claim: Cayenne Pepper (ID: 2006)

EFSA Claim: Cayenne Pepper (ID: 2006)

- by European Food Safety Authority (EFSA) European Food Safety Authority (EFSA) health claim: Contributes to weight reduction. Support in weight...
EFSA Claim: Yerba Mate (ID:2070)

EFSA Claim: Yerba Mate (ID:2070)

- by European Food Safety Authority (EFSA) European Food Safety Authority (EFSA) health claim: Contributes to body weight management. Contributes to...
EFSA Claim: Yerba Mate (ID: 3924)

EFSA Claim: Yerba Mate (ID: 3924)

- by European Food Safety Authority (EFSA) European Food Safety Authority (EFSA) health claim: Contributes to body weight management. Contributes...
Adverse effects of plant food supplements and botanical preparations

Adverse effects of plant food supplements and botanical preparations

- by C. Di Lorenzo et al. (2014) Aims The objective of this review was to collect available data on the following:...
The effect of weight loss in obese patients with heart failure

The effect of weight loss in obese patients with heart failure

- by Mikkelsen, M. G. (2011). Introduction Dietary recommendations in heart failure management are contradictory to findings established by the obesity paradox....
Formula Diet Plus Free Additional Food Choice up to 1000 Kcal (4.2 MJ)

Formula Diet Plus Free Additional Food Choice up to 1000 Kcal (4.2 MJ)

- by H. Hey, et al. (1987). Introduction The Formula diet NUPO meets all international recommendations for daily intakes of protein,...
A Review on Pharmacological and Phytochemical Properties of Zingiber officinale Roscoe (Zingiberaceae)

A Review on Pharmacological and Phytochemical Properties of Zingiber officinale Roscoe (Zingiberaceae)

- by Gaurav Kumar et al. (2011) Introduction Herbs and plants have been in use as a source of therapeutic compounds in...
Assessment report on Zingiber officinale Roscoe, rhizoma

Assessment report on Zingiber officinale Roscoe, rhizoma

- by European Medicines Agency (2012) Introduction Ginger (Zingiberis rhizoma) consists of the whole or cut rhizome of Zingiber officinale Roscoe...
Fabenol® Max, a standardised aqueous extract from Phaseolus vulgaris L.

Fabenol® Max, a standardised aqueous extract from Phaseolus vulgaris L.

- by European Food Safety Authority (EFSA) (2014) Abstract Following an application from Ecopharma BVBA, submitted for authorisation of a health claim...
Scientific Opinion on the substantiation of a health claim related to a standardised aqueous extract from white kidney bean

Scientific Opinion on the substantiation of a health claim related to a standardised aqueous extract from white kidney bean

- by European Food Safety Authority (EFSA) (2014) Abstract Following an application from InQpharm Europe Ltd, submitted for authorisation of a health...
Re-evaluation of konjac gum (E 425 I) and konjac glucomannan (E 425 II) as food additives

Re-evaluation of konjac gum (E 425 I) and konjac glucomannan (E 425 II) as food additives

- by European Food Safety Authority (EFSA) (2017) Abstract The present opinion deals with the re-evaluation of konjac (E 425), comprising konjac...
Scientific Opinion on the substantiation of health claims related to Konjac Mannan (Glucomannan)

Scientific Opinion on the substantiation of health claims related to Konjac Mannan (Glucomannan)

- by European Food Safety Authority (EFSA) (2010) Summary Following a request from the European Commission, the Panel on Dietetic Products, Nutrition...
Investigations of the Endocannabinoid System* in Adipose Tissue

Investigations of the Endocannabinoid System* in Adipose Tissue

- by Bennetzen, M. F. (2011). Introduction The study aimed to establish whether 10% weight loss would affect components of the ECS...
Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss

Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss

- by T. Christiansen, et al. (2009). Introduction Obesity, in particular excess visceral adipose tissue (VAT), is associated with the metabolic syndrome...
Twenty-four-hour plasma tryptophan concentrations

Twenty-four-hour plasma tryptophan concentrations

- by L. Breum, et al. (2003). Introduction Plasma tryptophan concentrations and the ratio of tryptophan to other large neutral amino acids...
Bone Loss Accompanying Voluntary Weight Loss in Obese Humans

Bone Loss Accompanying Voluntary Weight Loss in Obese Humans

- by L. Bjørn et al. (1994). Introduction Some studies have demonstrated that a diet-induced weight-loss is accompanied by a significant decrease...
Effect of an energy-restrictiv diet, with or without exercise, on lean tissue mass

Effect of an energy-restrictiv diet, with or without exercise, on lean tissue mass

- by O. L. Svendsen, et al. (1993). Introduction Overweight is an independent predictor of cardiovascular disease (CVD) – leading cause of...
Dietary fibre added to very low calorie diet reduces hunger and alleviates constipation

Dietary fibre added to very low calorie diet reduces hunger and alleviates constipation

- by A. Astrup et al. (1990). Introduction Very low calorie diet (VLCD) as a nutrition, powder formula diet is being widely...
Initial Very Low Calorie Diet VLCD improves ultimate weight loss

Initial Very Low Calorie Diet VLCD improves ultimate weight loss

- by Quaade, F. & Astrup, A. (1989). Introduction Very Low Calorie Diet (VLCD) if it is of an adequate composition,...
Gastroplasty Preceded by Very-Low-Calorie-Diet | A Preliminary Report

Gastroplasty Preceded by Very-Low-Calorie-Diet | A Preliminary Report

- by T. Andersen, et al. (1986). Introduction Gastroplasty (GP) performed in morbidly obese patients is fraught with an unavoidable perioperative...

Caloriearm Dieet

One Meal

Supplementen

Product bundels

Snacks

Accessoires

Winkelmand

Caloriearm Dieet

One Meal

Supplementen

Product bundels

Snacks

Accessoires

Winkelmand

Caloriearm Dieet

One Meal

Supplementen

Product bundels

Snacks

Accessoires

Nupo | Klinische onderzoeken

Gebruikersnaam
Wachtwoord

	Onthoud mij Wachtwoord vergeten? Registreren